We are live on
!
Find out more
Anavex Life Sciences
AVXL
AVXL
58 hedge funds and large institutions have $53.8M invested in Anavex Life Sciences in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
81% more capital invested
Capital invested by funds: $29.7M → $53.8M (+$24.1M)
38% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 8
3.84% more ownership
Funds ownership: 18.95% → 22.79% (+3.8%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 18
2% less funds holding
Funds holding: 59 → 58 (-1)
83% less call options, than puts
Call options by funds: $1.34M | Put options by funds: $7.66M
Holders
58
Holders Change
-1
Holders Change %
-1.69%
% of All Funds
1.44%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
18
Reduced
18
Closed
8
Calls
$1.34M
Puts
$7.66M
Net Calls
-$6.32M
Net Calls Change
-$778K
Top Buyers
| 1 |
BlackRock
New York
|
+$8.28M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$7.55M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$886K |
| 4 |
State Street
Boston,
Massachusetts
|
+$686K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$387K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$454K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$292K |
| 3 |
TCIM
TIAA CREF Investment Management
New York
|
-$222K |
| 4 |
Citigroup
New York
|
-$155K |
| 5 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
-$115K |
